Zoster

The Pharmacy Times® Zoster resource center provides clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

What can we help you find?
[[thumbnail_alt_text]]
A genetically edited form of herpes simplex virus altered to prevent it from avoiding an immune response outperformed a leading vaccine candidate.
 
[[thumbnail_alt_text]]
With more awareness of the susceptibility to coinfection with varicella zoster virus and pneumocystic jirovecii,  clinicians should aggressively seek signs of opportunistic infections in susceptible patients and treat them accordingly.
 
[[thumbnail_alt_text]]
Study suggests herpes simplex virus type 1 infection can spread to the fetal brain during pregnancy.
 
[[thumbnail_alt_text]]
Even in a relatively asymptomatic case of COVID-19, it is possible that the virus could have fostered retrograde reactivation of the varicella-zoster virus.
 
[[thumbnail_alt_text]]
Dissecting the mechanisms of this immunomodulation could provide important insights into varicella zoster virus pathogenesis and will be important when designing new vaccines and antivirals.
 
[[thumbnail_alt_text]]
Researchers found that herpes prevalence increased steadily with age, with the lowest rates among those aged 20 years or younger and the highest rates among those aged 50 years and older.
 
[[thumbnail_alt_text]]
Herpes zoster, commonly known as shingles, is often painful and in some cases last more than a year.
[[thumbnail_alt_text]]
Due to the suboptimal rates of live-attenuated varicella vaccination, outbreaks of varicella-zoster virus still occur, causing incidence of both varicella and herpes zoster.
[[thumbnail_alt_text]]
The physical and emotional stress of a COVID-19 diagnosis might be the triggering factor for the development of herpes zoster ophthalmicus.
 
[[thumbnail_alt_text]]
Although herpes zoster is rare in children, a case study suggests that it can develop in immunocompetent children after vaccination.